Zepp Health (NYSE:ZEPP) PT Set at $13.87 by Fundamental Research
Fundamental Research set a $13.87 target price on Zepp Health (NYSE:ZEPP – Free Report) in a report released on Tuesday,BayStreet.CA reports. The firm currently has a buy rating on the stock. Zepp Health Stock Up 4.1 % Shares of NYSE:ZEPP opened at $3.08 on Tuesday. Zepp Health has a 52-week low of $2.06 and a […]
More Stories
Bristol Myers Squibb Company (NYSE:BMY) Shares Sold by Spire Wealth Management
Spire Wealth Management reduced its position in shares of Bristol Myers Squibb Company (NYSE:BMY – Free Report) by 1.6% in...
Golden State Wealth Management LLC Acquires 974 Shares of Zoetis Inc. (NYSE:ZTS)
Golden State Wealth Management LLC increased its holdings in Zoetis Inc. (NYSE:ZTS – Free Report) by 90.6% in the first...
Zoetis Inc. (NYSE:ZTS) Shares Sold by Bessemer Group Inc.
Bessemer Group Inc. decreased its stake in shares of Zoetis Inc. (NYSE:ZTS – Free Report) by 42.6% during the 1st...
Golden State Wealth Management LLC Acquires 4,508 Shares of CSX Corporation (NASDAQ:CSX)
Golden State Wealth Management LLC increased its holdings in shares of CSX Corporation (NASDAQ:CSX – Free Report) by 123.1% in...
Golden State Wealth Management LLC Grows Stake in Meta Platforms, Inc. (NASDAQ:META)
Golden State Wealth Management LLC grew its position in Meta Platforms, Inc. (NASDAQ:META – Free Report) by 151.1% during the...
Golden State Wealth Management LLC Has $319,000 Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Golden State Wealth Management LLC increased its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 623.1% during the...